3-(1-(6-Amino-9H-purin-9-yl)propyl)-2-(4-(trifluoromethoxy)phenyl)-2H-benzo[e][1,2,4]thiadiazine 1,1-dioxide

ID: ALA4465857

Chembl Id: CHEMBL4465857

PubChem CID: 130337541

Max Phase: Preclinical

Molecular Formula: C22H18F3N7O3S

Molecular Weight: 517.49

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  CCC(C1=Nc2ccccc2S(=O)(=O)N1c1ccc(OC(F)(F)F)cc1)n1cnc2c(N)ncnc21

Standard InChI:  InChI=1S/C22H18F3N7O3S/c1-2-16(31-12-29-18-19(26)27-11-28-21(18)31)20-30-15-5-3-4-6-17(15)36(33,34)32(20)13-7-9-14(10-8-13)35-22(23,24)25/h3-12,16H,2H2,1H3,(H2,26,27,28)

Standard InChI Key:  UCTLAJVOPFKJCO-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA4465857

    ---

Associated Targets(Human)

PIK3R1 Tchem PI3-kinase p110-delta/p85-alpha (1508 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 517.49Molecular Weight (Monoisotopic): 517.1144AlogP: 4.20#Rotatable Bonds: 5
Polar Surface Area: 128.59Molecular Species: NEUTRALHBA: 9HBD: 1
#RO5 Violations: 1HBA (Lipinski): 10HBD (Lipinski): 2#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 4.07CX LogP: 4.33CX LogD: 4.33
Aromatic Rings: 4Heavy Atoms: 36QED Weighted: 0.42Np Likeness Score: -1.07

References

1. Ma X, Wei J, Wang C, Gu D, Hu Y, Sheng R..  (2019)  Design, synthesis and biological evaluation of novel benzothiadiazine derivatives as potent PI3Kδ-selective inhibitors for treating B-cell-mediated malignancies.,  170  [PMID:30878826] [10.1016/j.ejmech.2019.03.005]

Source